Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
207 participants
INTERVENTIONAL
2017-09-25
2027-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Printed Education Materials in Patients Who Are Finishing Treatment for Stage I, Stage II, or Stage IIIA Breast Cancer, Colorectal Cancer, Prostate Cancer, or Chest Cancer
NCT00372840
Computer-Based Survey and Communication Aid in Improving Physician-Patient Communication and Treatment Decision Making in Patients With Metastatic Cancer
NCT00244868
Using Whole-Person-Care Guide in Patients Receiving Care for Cancer or Complications From Cancer Treatment
NCT00608738
Testing an Educational Program to Improve Goals of Care Conversations Between Patients and Their Care Teams
NCT07278739
Communication Strategies to Introduce Psychology Services
NCT03035448
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
I. To compare patients' perception of helpfulness in communicating with their physicians between a question prompt sheet (QPS) and a general information sheet (GIS).
SECONDARY OBJECTIVES:
I. To compare caregivers' perception of helpfulness in communicating with their physicians between the QPS and the GIS.
II. To examine the level of patients' and caregivers' overall satisfaction with the consultation with the use of the QPS versus the GIS.
III. To examine physicians' views about the information material and overall satisfaction with the use of the QPS versus the GIS.
IV. To explore how the use of QPS affects the average speaking time of patient or physician during the consultation visit.
V. To establish demographic and clinical predictors of patients' perception of helpfulness of a QPS.
VI. To examine the overall patients' preference between the QPS and GIS in an open label phase.
VII. To compare the change in patient anxiety state with the use of the QPS versus the GIS.
VIII. To explore the factors underlying patients' preferences for the QPS or GIS.
OUTLINE: Participants are randomized into 1 of 2 groups.
GROUP I: Participants receive QPS and answer questions from physician. At follow up visit, participants receive both QPS and GIS.
GROUP II: Participants receive GIS and answer questions from physician. At follow up visit, participants receive both QPS and GIS.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group I (QPS)
Participants receive QPS and answer questions from physician. At follow up visit, participants receive both QPS and GIS.
Informational Intervention
Receive QPS
Questionnaire Administration
Ancillary studies
Group II (GIS)
Participants receive GIS and answer questions from physician. At follow up visit, participants receive both QPS and GIS.
Informational Intervention
Receive GIS
Questionnaire Administration
Ancillary studies
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Informational Intervention
Receive QPS
Informational Intervention
Receive GIS
Questionnaire Administration
Ancillary studies
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* (Patient participation) Normal cognitive status, defined as a normal state of arousal and an absence of obvious clinical findings of confusion, memory deficits or concentration deficits, as determined by the patient's physician
* (Patient participation) Ability to read and communicate in English
* (Patient participation) Diagnosis of advanced cancer
* (Patient participation) Signed written informed consent form
* (Caregiver participation) accompanied the patient to the clinic visit
* (Caregiver participation) is identified by the patient as someone who is actively involved in their overall care
* (Caregiver participation) is able to read and communicate in English
* (Caregiver participation) is willing to participate in the study and able to complete the questionnaires
* (Physician participation) a palliative medicine specialist
* (Physician participation) seeing the patient in consultation on the day of the study
* (Physician participation) willing to participate in the study
Exclusion Criteria
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Cancer Institute (NCI)
NIH
M.D. Anderson Cancer Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Joseph A Arthur
Role: PRINCIPAL_INVESTIGATOR
M.D. Anderson Cancer Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
M D Anderson Cancer Center
Houston, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Arthur J, Pawate V, Lu Z, Yennurajalingam S, Azhar A, Reddy A, Epner D, Hui D, Tanco K, Delgado Guay MO, Vidal M, Chen M, Bruera E. Helpfulness of Question Prompt Sheet for Patient-Physician Communication Among Patients With Advanced Cancer: A Randomized Clinical Trial. JAMA Netw Open. 2023 May 1;6(5):e2311189. doi: 10.1001/jamanetworkopen.2023.11189.
Related Links
Access external resources that provide additional context or updates about the study.
University of Texas MD Anderson Cancer Center Website
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NCI-2018-01052
Identifier Type: REGISTRY
Identifier Source: secondary_id
2017-0028
Identifier Type: OTHER
Identifier Source: secondary_id
2017-0028
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.